{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:11:20Z","timestamp":1778602280596,"version":"3.51.4"},"reference-count":31,"publisher":"Walter de Gruyter GmbH","issue":"8","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2024-0539_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To establish and verify the prediction model of recurrent preeclampsia (PE) in pregnant women with a history of\u00a0PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0539_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Totally 130 pregnant women with a history of PE from Jan 2021 to Jan 2023 were selected retrospectively. The patients were randomly matched according to the proportion of 1:4 to establish a verification group (nasty 26) and a modeling group (nasty 104). The modeling patients were divided into two groups according to the occurrence of preeclampsia: recurrent group (nasty 50) and non-recurrent group (nasty 54). Multivariate logistic regression analysis of influencing factors was established. Calibration curve was performed to verify, decision curve analysis (DCA) was used to evaluate the clinical practicability of the prediction model, and ROC analysis was used to show the prediction value of the\u00a0model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0539_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multivariate logistic regression analysis showed that there were significant differences in age, gestational age, gestational interval, systolic blood pressure and diastolic blood pressure of previous pregnancy. (p&lt;0.05) According to the results of logistic regression analysis, a prediction model was constructed. Logit(P)=(0.910Age)+(0.987Age of onset of previous pregnancy)+(1.167Gestational interval)+(1.186Systolic blood pressure in previous pregnancy)+(0.970Diastolic blood pressure in previous pregnancy).The slope of the calibration curve was close to one in the training set and verification set. The results showed that the prediction of recurrent PE risk of pregnant women with history of eclampsia was consistent with the actual risk. ROC analysis showed that the area under curve was 0.991. The results of DCA analysis showed that the model had good clinical practicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0539_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, a prediction model is successfully established and verified according to the influencing factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2024-0539","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T07:57:39Z","timestamp":1753171059000},"page":"1054-1061","source":"Crossref","is-referenced-by-count":0,"title":["Factors influencing recurrence of preeclampsia in pregnant women with a history of preeclampsia and the establishment of a predictive model"],"prefix":"10.1515","volume":"53","author":[{"given":"Hui","family":"Dong","sequence":"first","affiliation":[{"name":"School of Medicine , Nankai University , Tianjin , China"},{"name":"Departments of Obstetrics , Tianjin Central Hospital of Gynecology Obstetrics , Tianjin , China"},{"name":"Tianjin Key Laboratory of Human Development and Reproductive Regulation , Tianjin Central Hospital of Gynecology Obstetrics , Tianjin , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics , Tianjin Central Hospital of Gynecology Obstetrics , Tianjin , China"},{"name":"Tianjin Medical University , Tianjin , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanju","family":"Jia","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics , Tianjin Central Hospital of Gynecology Obstetrics , Tianjin , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Cui","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics , Tianjin Central Hospital of Gynecology Obstetrics , Tianjin , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine , Nankai University , Tianjin , China"},{"name":"Departments of Obstetrics , Tianjin Central Hospital of Gynecology Obstetrics , Tianjin , China"},{"name":"Tianjin Key Laboratory of Human Development and Reproductive Regulation , Tianjin Central Hospital of Gynecology Obstetrics , Tianjin , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2026051215163771581_j_jpm-2024-0539_ref_001","doi-asserted-by":"crossref","unstructured":"Ismailova, I, Zame, Y, Akhmedzhanova, M, Sultanov, K, Tanzharykova, G. Pathogenetic role of a number of factors in the development and progression of preeclampsia with varying severity in pregnant women. Reprod Fertil Dev 2024;36. https:\/\/doi.org\/10.1071\/rd23214.","DOI":"10.1071\/RD23214"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_002","doi-asserted-by":"crossref","unstructured":"Ito, T, Takahashi, H, Horie, K, Nagayama, S, Ogoyama, M, Fujiwara, H. Confined placental mosaicism with trisomy 13 complicated by severe preeclampsia: a case report and literature review. J\u00a0Obstet Gynaecol Res 2024;50:1737\u201341. https:\/\/doi.org\/10.1111\/jog.16035.","DOI":"10.1111\/jog.16035"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_003","doi-asserted-by":"crossref","unstructured":"Jiang, H, Meng, T, Li, Z. Role of circular RNAs in preeclampsia (Review). Exp Ther Med 2024;28:372. https:\/\/doi.org\/10.3892\/etm.2024.12661.","DOI":"10.3892\/etm.2024.12661"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_004","doi-asserted-by":"crossref","unstructured":"Lundgaard, MH, Sinding, MM, Sorensen, AN, Handberg, A, Andersen, S, Andersen, SL. Maternal hypothyroidism and the risk of preeclampsia: a Danish national and regional study. Matern Health Neonatol Perinatol 2024;10:16. https:\/\/doi.org\/10.1186\/s40748-024-00186-4.","DOI":"10.1186\/s40748-024-00186-4"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_005","doi-asserted-by":"crossref","unstructured":"Sligo, J, Corfe-Tan, J, Cotter, Z, Eteuati, JS, Hart, HR, McConnell, R. Midwifery experiences in rural Southern Aotearoa New\u00a0Zealand: insights into pre-eclampsia management. N\u00a0Z Med J 2024;137:52\u201361. https:\/\/doi.org\/10.26635\/6965.6458.","DOI":"10.26635\/6965.6458"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_006","doi-asserted-by":"crossref","unstructured":"Saffian, E, Palatnik, A. Association between recurrent preeclampsia and attendance at the blood pressure monitoring appointment after birth. J\u00a0Obstet Gynecol Neonatal Nurs 2024;53:132\u20139. https:\/\/doi.org\/10.1016\/j.jogn.2023.11.002.","DOI":"10.1016\/j.jogn.2023.11.002"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_007","doi-asserted-by":"crossref","unstructured":"Han, S, Zhang, H, He, Y, Chen, Q. Clinical features of recurrent preeclampsia: a retrospective study of 109 recurrent preeclampsia patients. Hypertens Res 2024;47:1410\u20139. https:\/\/doi.org\/10.1038\/s41440-024-01623-9.","DOI":"10.1038\/s41440-024-01623-9"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_008","doi-asserted-by":"crossref","unstructured":"Tulin Gesoglu, D, Murat, C, Dilek, A, Ozlem, E, Sibel, S. Risk factors of posterior reversible encephalopathy syndrome in patients with preeclampsia or eclampsia: a retrospective review. Ideggyogy Sz 2024;77:247\u201354. https:\/\/doi.org\/10.18071\/isz.77.0247.","DOI":"10.18071\/isz.77.0247"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_009","doi-asserted-by":"crossref","unstructured":"Wu, C, Ling, Z, Wang, Y, Lv, Y, Miao, Z, Liu, L, et al.. Clinical analysis of risk factors and perinatal outcomes in recurrent pre-eclampsia with severe features. Reprod Sci 2024;31:2763\u201370. https:\/\/doi.org\/10.1007\/s43032-024-015294.","DOI":"10.1007\/s43032-024-01529-4"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_010","doi-asserted-by":"crossref","unstructured":"Zhang, L, Wang, W, Gong, J, Wang, X, Liang, J, Gu, S, et al.. Development, validation, and clinical utility of a risk prediction model for recurrent preeclampsia. J\u00a0Hypertens 2024;42:236\u201343. https:\/\/doi.org\/10.1097\/hjh.0000000000003580.","DOI":"10.1097\/HJH.0000000000003580"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_011","doi-asserted-by":"crossref","unstructured":"Stanciakova, L, Dobrotova, M, Ivankova, J, Skornova, I, Bolek, T, Brunclikova, M, et al.. At-risk pregnant woman with sticky platelet syndrome, previous recurrent preeclampsia, and current proteinuria - a rare experience. Rev Invest Clin 2023;75:45\u20136. https:\/\/doi.org\/10.24875\/RIC.22000307.","DOI":"10.24875\/RIC.22000307"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_012","doi-asserted-by":"crossref","unstructured":"Bijl, RC, Cornette, JMJ, Brewer, AN, Zwart, IF, Franx, A, Tsigas, EZ, et al.. Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia. Pregnancy Hypertens 2022;28:44\u201350. https:\/\/doi.org\/10.1016\/j.preghy.2022.02.003.","DOI":"10.1016\/j.preghy.2022.02.003"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_013","doi-asserted-by":"crossref","unstructured":"Lin, XM, Li, DZ. Prevention of recurrent preeclampsia in high-risk pregnancies: is it time for a paradigm shift? Am J Obstet Gynecol 2023;229:187\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2023.03.035.","DOI":"10.1016\/j.ajog.2023.03.035"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_014","doi-asserted-by":"crossref","unstructured":"Ma, Y, Ma, M, Ye, S, Liu, Y, Zhao, X, Wang, Y. Association of IL-17 and IL-27 polymorphisms with susceptibility to recurrent pregnancy loss and pre-eclampsia: a systematic review and meta-analysis. Immun Inflamm Dis 2023;11:e1057. https:\/\/doi.org\/10.1002\/iid3.1057.","DOI":"10.1002\/iid3.1057"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_015","doi-asserted-by":"crossref","unstructured":"Wainstock, T, Sheiner, E. Clinical factors associated with preeclampsia recurrence. Pregnancy Hypertens 2022;30:31\u20135. https:\/\/doi.org\/10.1016\/j.preghy.2022.08.004.","DOI":"10.1016\/j.preghy.2022.08.004"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_016","doi-asserted-by":"crossref","unstructured":"de Moreuil, C, Alavi, Z, Pasquier, E. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage. Br J Clin Pharmacol 2020;86:39\u201349. https:\/\/doi.org\/10.1111\/bcp.14131.","DOI":"10.1111\/bcp.14131"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_017","doi-asserted-by":"crossref","unstructured":"Stekkinger, E, Scholten, RR, Heidema, WM, Spaanderman, MEA. Comparison of three definitions of metabolic syndrome and relation to risk of recurrent preeclampsia. Hypertens Pregnancy 2021;40:97\u2013108. https:\/\/doi.org\/10.1080\/10641955.2021.1872614.","DOI":"10.1080\/10641955.2021.1872614"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_018","doi-asserted-by":"crossref","unstructured":"Zhang, Y, Shen, F, Yang, W, Wang, J, Zhou, J, Chen, Y. Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: a stratified cohort study. Int J Gynaecol Obstet 2021;154:337\u201342. https:\/\/doi.org\/10.1002\/ijgo.13535.","DOI":"10.1002\/ijgo.13535"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_019","doi-asserted-by":"crossref","unstructured":"Njoroge, S, Kuriloff, M, Mueller, A, Lopes Perdigao, J, Dhir, R, Rana, S. The interval between births and the risk of recurrent preeclampsia among predominantly high risk women in urban tertiary care center. Pregnancy Hypertens 2021;25:7\u201311. https:\/\/doi.org\/10.1016\/j.preghy.2021.05.009.","DOI":"10.1016\/j.preghy.2021.05.009"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_020","doi-asserted-by":"crossref","unstructured":"Mulder, EG, Ghossein-Doha, C, Cauffman, E, Lopes van Balen, VA, Schiffer, V, Alers, RJ, et al.. Preventing recurrent preeclampsia by tailored treatment of nonphysiologic hemodynamic adjustments to pregnancy. Hypertension 2021;77:2045\u201353. https:\/\/doi.org\/10.1161\/hypertensionaha.120.16502.","DOI":"10.1161\/HYPERTENSIONAHA.120.16502"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_021","doi-asserted-by":"crossref","unstructured":"Dong, X, Han, M, Zeb, S, Tong, M, Li, X, Chen, Q. Active management reduces the incidence of recurrent pre-eclampsia and improves maternal and fetal outcomes in women with recurrent pre-eclampsia. Front Med 2021;8:658022. https:\/\/doi.org\/10.3389\/fmed.2021.658022.","DOI":"10.3389\/fmed.2021.658022"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_022","doi-asserted-by":"crossref","unstructured":"Yu, Z, Zhang, W, Wang, Y, Gao, M, Zhang, M, Yao, D, et al.. Extracellular vesicles derived from human umbilical cord MSC improve vascular endothelial function in in\u00a0vitro and in\u00a0vivo models of preeclampsia through activating arginine metabolism. Mol Pharm 2023;20:6429\u201340. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00816.","DOI":"10.1021\/acs.molpharmaceut.3c00816"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_023","doi-asserted-by":"crossref","unstructured":"Yang, X, Benny, PA, Cervera-Marzal, E, Wu, B, Lassiter, CB, Astern, J, et al.. Placental telomere length shortening is not associated with severe preeclampsia but the gestational age. Aging (Albany NY) 2022;15:353\u201370. https:\/\/doi.org\/10.18632\/aging.204445.","DOI":"10.18632\/aging.204445"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_024","doi-asserted-by":"crossref","unstructured":"Shi, J, Wang, J, Jia, N, Sun, Q. A network pharmacology study on mechanism of resveratrol in treating preeclampsia via regulation of AGE-RAGE and HIF-1 signalling pathways. Front Endocrinol 2022;13:1044775. https:\/\/doi.org\/10.3389\/fendo.2022.1044775.","DOI":"10.3389\/fendo.2022.1044775"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_025","doi-asserted-by":"crossref","unstructured":"Mula, R, Prats, P, Garcia, S, Serra, B, Scazzocchio, E, Meler, E. Angiogenic factors assessment in pre-eclampsia high-risk population for the prediction of small-for-gestational age neonates: a prospective longitudinal study. Int J Gynaecol Obstet 2023;161:439\u201346. https:\/\/doi.org\/10.1002\/ijgo.14508.","DOI":"10.1002\/ijgo.14508"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_026","doi-asserted-by":"crossref","unstructured":"Liu, Y, Zhou, M, Cheng, H, Du, J. Effect of low-molecular-weight heparin calcium combined with magnesium sulfate and labetalol on coagulation, vascular endothelial function and pregnancy outcome in early-onset severe preeclampsia. Eur J Clin Pharmacol 2024;80:1495\u2013501. https:\/\/doi.org\/10.1007\/s00228-024-03712-7.","DOI":"10.1007\/s00228-024-03712-7"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_027","doi-asserted-by":"crossref","unstructured":"Deng, P, Yu, Q, Tang, H, Lu, Y, He, Y. Age at menarche mediating visceral adipose tissue\u2019s influence on pre-eclampsia: a mendelian randomization study. J\u00a0Clin Endocrinol Metab 2023;108:405\u201313. https:\/\/doi.org\/10.1210\/clinem\/dgac566.","DOI":"10.1210\/clinem\/dgac566"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_028","doi-asserted-by":"crossref","unstructured":"Chen, Z, Wu, M, Huang, H, Tao, H, Zou, L, Luo, Q. Correction: plasma exosomal miR-199a-5p derived from preeclampsia with severe features impairs endothelial cell function via targeting SIRT1. Reprod Sci 2024;31:579. https:\/\/doi.org\/10.1007\/s43032-023-01416-4.","DOI":"10.1007\/s43032-023-01416-4"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_029","doi-asserted-by":"crossref","unstructured":"Deng, Y, She, L, Li, X, Lai, W, Yu, L, Zhang, W, et al.. Monitoring hypertensive disorders in pregnancy to prevent preeclampsia in pregnant women of advanced maternal age: trial mimicking with retrospective data. Open Med 2022;17:1840\u20138. https:\/\/doi.org\/10.1515\/med-2022-0560.","DOI":"10.1515\/med-2022-0560"},{"key":"2026051215163771581_j_jpm-2024-0539_ref_030","unstructured":"Yan, W, Zhou, Y. The application effect of evidence-based targeted nursing in severe preeclamptic women and its impact on maternal psychological status, uality of life, and maternal-infant outcomes. Altern Ther Health Med 2025;31:414\u201321."},{"key":"2026051215163771581_j_jpm-2024-0539_ref_031","doi-asserted-by":"crossref","unstructured":"Jasper, EA, Hellwege, JN, Breeyear, JH, Xiao, B, Jarvik, GP, Stanaway, IB, et al.. Genetic predictors of blood pressure traits are associated with preeclampsia. Sci Rep 2024;14:17613. https:\/\/doi.org\/10.1038\/s41598-024-68469-6.","DOI":"10.1038\/s41598-024-68469-6"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0539\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0539\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:23:04Z","timestamp":1778599384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0539\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,5]]},"published-print":{"date-parts":[[2025,10,27]]}},"alternative-id":["10.1515\/jpm-2024-0539"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2024-0539","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}